{"hands_on_practices": [{"introduction": "Understanding the metabolic state of a T cell often begins with assessing its mitochondrial activity. This exercise simulates the analysis of data from a Seahorse mitochondrial stress test, a cornerstone assay in the field. By applying a series of metabolic inhibitors with known targets, you will learn to dissect the oxygen consumption rate ($OCR$) into its fundamental components, such as ATP-linked respiration and spare respiratory capacity. Mastering this quantitative analysis [@problem_id:2868684] is an essential skill for characterizing the bioenergetic phenotype of immune cells in various states of activation or differentiation.", "problem": "In human memory T cells, activation state and differentiation correlate with shifts in bioenergetic partitioning between glycolysis and mitochondrial oxidative phosphorylation. A standard mitochondrial stress test uses sequential perturbations to dissect contributions to the oxygen consumption rate (OCR). The following widely accepted mechanistic facts form the basis for quantitative decomposition of OCR: (i) oligomycin inhibits adenosine triphosphate (ATP) synthase, dropping OCR to a level reflecting proton leak plus non-mitochondrial oxygen consumption; (ii) carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) uncouples the proton gradient, revealing the maximal electron transport chain capacity; and (iii) rotenone and antimycin A inhibit mitochondrial complexes I and III, revealing non-mitochondrial oxygen consumption.\n\nYou are provided oxygen consumption rate measurements for purified human memory T cells during a Seahorse assay. Values are already normalized per well to $10^{5}$ cells and are reported in $\\mathrm{pmol\\ O_{2}\\ min^{-1}\\ per\\ 10^{5}\\ \\mathrm{cells}}$. For each phase, use the average of the last three steady cycles.\n\n- Basal (pre-injection) OCR: $128$, $132$, $130$.\n- After oligomycin injection: $78$, $80$, $79$.\n- After FCCP injection: $210$, $205$, $208$.\n- After rotenone/antimycin A injection: $20$, $19$, $21$.\n\nUsing only the mechanistic facts above and first principles of how each perturbation isolates specific OCR components, compute:\n- Basal mitochondrial respiration.\n- ATP-linked respiration.\n- Spare respiratory capacity.\n\nReport your answer as a row matrix in the order $[\\text{basal mitochondrial respiration},\\ \\text{ATP-linked respiration},\\ \\text{spare respiratory capacity}]$, in the unit $\\mathrm{pmol\\ O_{2}\\ min^{-1}\\ per\\ 10^{5}\\ \\mathrm{cells}}$, and round each entry to three significant figures in scientific notation. Do not include units in your final boxed answer.", "solution": "We start from the mechanistic definitions and how inhibitor responses isolate OCR components:\n\n- Oligomycin inhibits adenosine triphosphate (ATP) synthase, so OCR after oligomycin reflects proton leak plus non-mitochondrial oxygen consumption. The difference between basal OCR and oligomycin OCR therefore reflects ATP-linked respiration, because the non-mitochondrial component is present in both and cancels on subtraction.\n\n- Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) uncouples oxidative phosphorylation, collapsing the proton gradient to drive maximal electron transport chain flux. The OCR after FCCP (corrected for non-mitochondrial oxygen consumption) is the maximal mitochondrial respiration.\n\n- Rotenone/antimycin A inhibit complexes I and III, respectively, leaving only non-mitochondrial oxygen consumption; this provides the non-mitochondrial OCR to subtract from basal and FCCP phases when computing mitochondrial components.\n\nLet the phase means be:\n- Basal mean $B = \\dfrac{128 + 132 + 130}{3}$.\n- Oligomycin mean $O = \\dfrac{78 + 80 + 79}{3}$.\n- FCCP mean $F = \\dfrac{210 + 205 + 208}{3}$.\n- Rotenone/antimycin A mean (non-mitochondrial) $N = \\dfrac{20 + 19 + 21}{3}$.\n\nCompute the means:\n- $B = \\dfrac{390}{3} = 130$.\n- $O = \\dfrac{237}{3} = 79$.\n- $F = \\dfrac{623}{3} = 207.\\overline{6}$.\n- $N = \\dfrac{60}{3} = 20$.\n\nNow derive the components:\n\n1. Basal mitochondrial respiration equals basal OCR corrected for non-mitochondrial oxygen consumption:\n$$\n\\text{Basal mitochondrial respiration} = B - N = 130 - 20 = 110.\n$$\n\n2. ATP-linked respiration equals the drop in OCR upon oligomycin, which removes ATP synthase activity while leaving non-mitochondrial oxygen consumption unchanged:\n$$\n\\text{ATP-linked respiration} = B - O = 130 - 79 = 51.\n$$\n\n3. Spare respiratory capacity equals the difference between maximal mitochondrial respiration and basal mitochondrial respiration. Since both maximal and basal are corrected by subtracting the same non-mitochondrial oxygen consumption $N$, this is equivalently the difference between the FCCP and basal means:\n$$\n\\text{Spare capacity} = (F - N) - (B - N) = F - B = 207.\\overline{6} - 130 = 77.\\overline{6}.\n$$\n\nConvert each to scientific notation and round to three significant figures:\n\n- Basal mitochondrial respiration: $110 = 1.10 \\times 10^{2}$.\n- ATP-linked respiration: $51 = 5.10 \\times 10^{1}$.\n- Spare respiratory capacity: $77.\\overline{6} \\approx 77.7 = 7.77 \\times 10^{1}$.\n\nThese values are expressed per $10^{5}$ cells in $\\mathrm{pmol\\ O_{2}\\ min^{-1}}$ as specified.", "answer": "$$\\boxed{\\begin{pmatrix}1.10 \\times 10^{2} & 5.10 \\times 10^{1} & 7.77 \\times 10^{1}\\end{pmatrix}}$$", "id": "2868684"}, {"introduction": "While measuring overall oxygen consumption is informative, a deeper understanding requires tracing the fate of specific nutrients within the complex web of intracellular metabolic pathways. This practice introduces the powerful technique of stable isotope tracing, using data from a hypothetical $^{13}$C-labeling experiment. You will act as a metabolic detective, using the mass distribution of labeled citrate to deduce the activity of a non-canonical pathway—reductive carboxylation—a key adaptation of T cells in hypoxic environments [@problem_id:2868615]. This exercise builds intuition for interpreting flux data, which is central to modern metabolic research.", "problem": "Activated T lymphocytes exposed to low oxygen tension undergo metabolic reprogramming that alters tricarboxylic acid (TCA) cycle routing. Consider an experiment in which activated T cells are incubated under hypoxia for a short labeling period with uniformly labeled glutamine, denoted [U-$^{13}$C]glutamine (that is, all five carbons of glutamine are $^{13}$C), while glucose and dissolved inorganic carbon ($\\text{CO}_2$/$\\text{HCO}_3^-$) are unlabeled. Under hypoxia, pyruvate dehydrogenase (PDH) activity is negligible, so acetyl coenzyme A (acetyl-CoA) supplying the TCA cycle is effectively unlabeled during the pulse. Natural abundance corrections have been applied to all isotopologue measurements. The measured mass isotopologue distribution (MID) of citrate after the pulse is: $f_{M+0} = 0.58$, $f_{M+4} = 0.19$, $f_{M+5} = 0.23$, and $f_{M+k} = 0$ for all other $k$. Assume that the observed citrate pool is a mixture of a pre-existing unlabeled pool and newly synthesized citrate molecules formed during the labeling period. Using only foundational carbon accounting for the oxidative TCA cycle and the isocitrate dehydrogenase (IDH)-mediated reductive carboxylation of $\\alpha$-ketoglutarate, infer the fraction (as a decimal between $0$ and $1$) of newly synthesized citrate molecules that arose via reductive carboxylation during the labeling interval. Express your answer as a decimal fraction and round your answer to four significant figures.", "solution": "The problem is first subjected to validation.\n\n**Step 1: Extract Givens**\n- **System:** Activated T lymphocytes under hypoxia.\n- **Labeled Substrate:** Uniformly labeled glutamine, [U-$^{13}$C]glutamine ($5$ carbons are $^{13}$C).\n- **Unlabeled Substrates:** Glucose, dissolved inorganic carbon (CO$_{2}$/HCO$_{3}^{-}$).\n- **Condition:** Pyruvate dehydrogenase (PDH) activity is negligible.\n- **Consequence:** Acetyl coenzyme A (acetyl-CoA) is effectively unlabeled ($M+0$).\n- **Data:** Measured mass isotopologue distribution (MID) of citrate, corrected for natural abundance: $f_{M+0} = 0.58$, $f_{M+4} = 0.19$, $f_{M+5} = 0.23$, and $f_{M+k} = 0$ for all other $k$.\n- **Assumption:** The total citrate pool is a mixture of a pre-existing unlabeled pool and newly synthesized citrate.\n- **Pathways:** Oxidative tricarboxylic acid (TCA) cycle and isocitrate dehydrogenase (IDH)-mediated reductive carboxylation of $\\alpha$-ketoglutarate.\n- **Objective:** Calculate the fraction of newly synthesized citrate that arose via reductive carboxylation, rounded to four significant figures.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically grounded, describing a standard $^{13}$C metabolic flux analysis experiment in immunology. The stated conditions (hypoxia, negligible PDH activity) and pathways (reductive carboxylation) are well-established phenomena in cancer and immune cell metabolism. The problem is well-posed, providing sufficient quantitative data ($f_{M+k}$) and clear biochemical constraints to deduce the requested fraction. The language is objective and precise. The problem does not violate any criteria for invalidity.\n\n**Step 3: Verdict and Action**\nThe problem is valid. A solution will be derived.\n\n**Derivation of Solution**\nThe problem requires tracing the carbon atoms from [U-$^{13}$C]glutamine to citrate through two distinct metabolic routes. Let $M+k$ denote a molecule (isotopologue) containing $k$ atoms of $^{13}$C in excess of natural abundance.\n\n1.  **Carbon Tracing for the Oxidative Pathway**\n    The starting labeled substrate is [U-$^{13}$C]glutamine, which has $5$ carbons, all labeled. This is a $M+5$ species. Glutamine is converted to glutamate and then to $\\alpha$-ketoglutarate (AKG) without loss of carbon atoms. Therefore, the resulting AKG is also fully labeled, an AKG $M+5$ isotopologue.\n    In the oxidative TCA cycle, the $5$-carbon AKG ($M+5$) is decarboxylated by the AKG dehydrogenase complex to form $4$-carbon succinyl-CoA. This reaction releases one molecule of $\\text{CO}_2$. Since the AKG is fully labeled, the released $\\text{CO}_2$ is $^{13}\\text{CO}_2$, and one labeled carbon is lost. The resulting succinyl-CoA is therefore an $M+4$ species.\n    The subsequent steps of the TCA cycle (succinyl-CoA $\\rightarrow$ succinate $\\rightarrow$ fumarate $\\rightarrow$ malate $\\rightarrow$ oxaloacetate) are a series of conversions on a $4$-carbon backbone. No further carbon atoms are lost or gained. Thus, the oxaloacetate (OAA) formed at the end of this sequence is an $M+4$ species.\n    Finally, citrate is formed by the condensation of this OAA($M+4$) with acetyl-CoA. The problem states that PDH activity is negligible, so glucose does not contribute to the acetyl-CoA pool, which is considered unlabeled ($M+0$). The reaction catalyzed by citrate synthase is:\n    $$ \\text{OAA}(M+4) + \\text{Acetyl-CoA}(M+0) \\rightarrow \\text{Citrate}(M+4) $$\n    Thus, the oxidative pathway exclusively produces citrate $M+4$.\n\n2.  **Carbon Tracing for the Reductive Pathway**\n    This pathway also starts with AKG($M+5$) derived from labeled glutamine. The enzyme isocitrate dehydrogenase (IDH), operating in the reverse (reductive) direction, catalyzes the carboxylation of AKG to form isocitrate. The source of the additional carbon is the unlabeled pool of dissolved $\\text{CO}_2$/$\\text{HCO}_3^-$. The reaction is:\n    $$ \\text{AKG}(M+5) + \\text{CO}_2(M+0) + \\text{NADPH} \\rightarrow \\text{Isocitrate}(M+5) + \\text{NADP}^+ $$\n    The resulting $6$-carbon isocitrate molecule contains the $5$ labeled carbons from AKG and $1$ unlabeled carbon from $\\text{CO}_2$, making it an $M+5$ species. Isocitrate is in rapid equilibrium with citrate via the enzyme aconitase. Therefore, the reductive pathway exclusively produces citrate $M+5$.\n\n3.  **Quantitative Analysis of the Citrate Pool**\n    The observed citrate pool is a mixture. Let $f_{new}$ be the fraction of the total citrate pool that is newly synthesized during the labeling period. The remainder, $1 - f_{new}$, is the fraction of pre-existing, unlabeled citrate.\n    The newly synthesized citrate is composed of molecules from the oxidative pathway ($M+4$) and the reductive pathway ($M+5$). The measured MID shows that the only labeled species are $M+4$ and $M+5$. Therefore, the total fraction of newly synthesized citrate is the sum of their fractional abundances:\n    $$ f_{new} = f_{M+4} + f_{M+5} $$\n    Substituting the given values:\n    $$ f_{new} = 0.19 + 0.23 = 0.42 $$\n    This implies that $42\\%$ of the total citrate pool was synthesized during the labeling period. The remaining fraction is $1 - f_{new} = 1 - 0.42 = 0.58$, which is entirely unlabeled ($M+0$). This calculated value matches the given $f_{M+0} = 0.58$, confirming the consistency of the model.\n\n    The problem asks for the fraction of *newly synthesized* citrate that arose via reductive carboxylation. Let this fraction be $r$. By definition, this is the ratio of the amount of citrate produced via the reductive path to the total amount of newly synthesized citrate. Using the fractional abundances from the MID as a measure of these amounts:\n    $$ r = \\frac{\\text{Abundance of reductively synthesized citrate}}{\\text{Total abundance of newly synthesized citrate}} $$\n    The reductively synthesized citrate is the $M+5$ species, and the total newly synthesized pool consists of the $M+4$ and $M+5$ species.\n    $$ r = \\frac{f_{M+5}}{f_{M+4} + f_{M+5}} $$\n    Substituting the numerical values:\n    $$ r = \\frac{0.23}{0.19 + 0.23} = \\frac{0.23}{0.42} $$\n    Calculating the value:\n    $$ r \\approx 0.5476190... $$\n    The problem requires the answer to be rounded to four significant figures.\n    $$ r \\approx 0.5476 $$", "answer": "$$\\boxed{0.5476}$$", "id": "2868615"}, {"introduction": "The interplay between metabolism and cell fate is governed by complex regulatory networks. This advanced exercise challenges you to translate biological principles into a quantitative, predictive model of T cell differentiation. You will implement a signaling logic model that formalizes how environmental cues like oxygen availability are integrated with cytokine signals to control the balance between Th17 and Treg cells [@problem_id:2868713]. This practice in computational systems biology demonstrates how we can build \"in silico\" experiments to test our understanding of immunometabolism and predict cellular behavior.", "problem": "You are asked to formalize a biologically grounded signaling logic model for T helper type 17 (Th17) versus regulatory T cell (Treg) differentiation driven by oxygen availability and cytokine inputs, and then compute a scalar bias score for predefined cases. Your program must implement the model, evaluate it on a fixed test suite of input parameter sets, and output the results in the specified single-line format. All signals are dimensionless and normalized to the interval $\\left[0,1\\right]$.\n\nBase biological principles to use:\n- Hypoxia-Inducible Factor $1\\alpha$ (HIF-1$\\alpha$) is stabilized under low oxygen and promotes glycolytic metabolism while directly enhancing RAR-related orphan receptor gamma t (ROR$\\gamma$t) activity and antagonizing Forkhead box P3 (FOXP3).\n- Interleukin $6$ (IL-$6$) activates Signal Transducer and Activator of Transcription $3$ (STAT$3$), supporting Th$17$.\n- Interleukin $2$ (IL-$2$) activates Signal Transducer and Activator of Transcription $5$ (STAT$5$), supporting Treg with Transforming Growth Factor beta (TGF-$\\beta$).\n- Mechanistic Target Of Rapamycin (mTOR) activity integrates nutrient sufficiency and supports glycolysis.\n\nDefine the following monotone operators and transfer functions:\n- Hill activation $A(x;K,n) = \\dfrac{x^{n}}{K^{n} + x^{n}}$ for $x \\in \\left[0,1\\right]$, with $K \\in \\left(0,1\\right)$ and $n \\ge 1$.\n- Logical operators on $\\left[0,1\\right]$:\n  - $NOT(x) = 1 - x$,\n  - $AND(a,b) = a \\cdot b$,\n  - $OR(a,b) = 1 - \\left(1-a\\right)\\left(1-b\\right)$.\n\nModel specification:\n1. Oxygen is $O \\in \\left[0,1\\right]$, where larger $O$ means more oxygen (less hypoxia). HIF stabilization is modeled as a decreasing Hill function of oxygen:\n   $$H(O) = \\dfrac{K_H^{n_H}}{K_H^{n_H} + O^{n_H}}$$,\n   with $K_H = 0.3$ and $n_H = 3$.\n2. Cytokine transducers:\n   $$S_3 = A(IL6;K_6,n_6), \\quad S_5 = A(IL2;K_2,n_2), \\quad T = A(TGF;K_T,n_T)$$,\n   with shared constants $K_6 = K_2 = K_T = 0.5$ and $n_6 = n_2 = n_T = 2$.\n3. Glycolysis proxy $G$ integrates HIF and mTOR by a soft $OR$:\n   $$G = OR(H, M) = 1 - \\left(1-H\\right)\\left(1-M\\right)$$,\n   where $M \\in \\left[0,1\\right]$ is mTOR input.\n4. Th$17$ master transcription factor ROR$\\gamma$t activity $R$ is a Hill transform of a soft $OR$ between STAT$3$ and glycolysis:\n   $$R_{\\text{base}} = OR(S_3, G), \\quad R = A(R_{\\text{base}};K_R,n_R)$$,\n   with $K_R = 0.5$ and $n_R = 2$.\n5. Treg master transcription factor FOXP$3$ activity $F$ is a Hill transform of the product of TGF-$\\beta$ and STAT$5$, antagonized by HIF-1$\\alpha$:\n   $$F_{\\text{base}} = AND(T,S_5) = T \\cdot S_5, \\quad F_{\\text{inh}} = F_{\\text{base}} \\cdot NOT(H), \\quad F = A(F_{\\text{inh}};K_F,n_F)$$,\n   with $K_F = 0.5$ and $n_F = 2$.\n6. The Th$17$ bias score is defined as the normalized share of $R$ over the sum of $R$ and $F$:\n   $$B = \\dfrac{R}{R + F + \\delta}$$,\n   where $\\delta = 10^{-9}$ avoids division by zero.\n\nInputs and test suite:\n- Each test case is a $5$-tuple $(O, IL6, IL2, TGF, M)$ with all entries in $\\left[0,1\\right]$.\n- Use the following test suite to evaluate the model:\n  - Case $1$: $(O, IL6, IL2, TGF, M) = (0.05, 0.8, 0.2, 0.6, 0.7)$.\n  - Case $2$: $(O, IL6, IL2, TGF, M) = (0.9, 0.8, 0.2, 0.6, 0.7)$.\n  - Case $3$: $(O, IL6, IL2, TGF, M) = (0.9, 0.1, 0.9, 0.6, 0.3)$.\n  - Case $4$: $(O, IL6, IL2, TGF, M) = (0.1, 0.0, 0.0, 0.0, 0.0)$.\n  - Case $5$: $(O, IL6, IL2, TGF, M) = (0.01, 0.2, 1.0, 0.8, 0.5)$.\n  - Case $6$: $(O, IL6, IL2, TGF, M) = (0.2, 0.5, 0.4, 0.7, 0.9)$.\n\nTask:\n- Implement the above functions precisely.\n- For each test case, compute $B$ as defined above.\n- Your program should produce a single line of output containing the results as a comma-separated list of real numbers rounded to $6$ decimal places, enclosed in square brackets. For example, an output with three cases should look like $[0.123456,0.654321,0.500000]$.", "solution": "The problem statement has been rigorously assessed and is deemed valid. It is scientifically grounded in established immunological principles, albeit simplified for a computational model. The mathematical formalism is well-defined, internally consistent, and contains all necessary information for a unique solution. It is a well-posed problem in computational systems biology.\n\nThe task is to implement a signaling logic model for T helper type $17$ (Th$17$) versus regulatory T cell (Treg) differentiation and compute a bias score, $B$, for several input conditions. The logic is based on the interplay of oxygen availability, cytokine signals, and metabolic state.\n\nFirst, we define the necessary mathematical operators. The Hill activation function, which models a cooperative, saturating response, is given by:\n$$ A(x; K, n) = \\frac{x^n}{K^n + x^n} $$\nwhere $x$ is the input signal, $K$ is the half-activation constant, and $n$ is the Hill coefficient signifying cooperativity. For this problem, all inputs $x$ are normalized to the interval $\\left[0, 1\\right]$.\n\nThe logical operators are defined for variables on the continuous interval $\\left[0, 1\\right]$:\n- Logical NOT: $NOT(x) = 1 - x$\n- Logical AND: $AND(a, b) = a \\cdot b$\n- Logical OR: $OR(a, b) = 1 - (1-a)(1-b)$\n\nThe model proceeds sequentially.\n\n1.  **HIF-1$\\alpha$ Stabilization ($H$)**: Hypoxia-Inducible Factor $1\\alpha$ (HIF-$1\\alpha$) is a key transcription factor stabilized under low oxygen conditions. Its level, $H$, is modeled as an inverse function of oxygen concentration, $O \\in \\left[0, 1\\right]$, using an inhibitory Hill-like function:\n    $$ H(O) = \\frac{K_H^{n_H}}{K_H^{n_H} + O^{n_H}} $$\n    Here, $K_H = 0.3$ and $n_H = 3$. High $O$ leads to low $H$, and low $O$ leads to high $H$.\n\n2.  **Cytokine Transduction ($S_3, S_5, T$)**: The downstream effects of cytokines IL-$6$, IL-$2$, and TGF-$\\beta$ are modeled by activating their respective transcription factors STAT$3$, STAT$5$, and SMADs (proxied by $T$). These are all modeled with the standard Hill activation function $A(x;K,n)$ with shared parameters $K_6 = K_2 = K_T = 0.5$ and $n_6 = n_2 = n_T = 2$.\n    $$ S_3 = A(IL6; K_6, n_6) $$\n    $$ S_5 = A(IL2; K_2, n_2) $$\n    $$ T = A(TGF; K_T, n_T) $$\n\n3.  **Glycolysis Proxy ($G$)**: The glycolytic state, $G$, is a key metabolic feature of Th$17$ cells. It is promoted by both HIF-$1\\alpha$ (under hypoxia) and mTOR activity, $M$ (under nutrient sufficiency). This integration is modeled using the logical $OR$ operator:\n    $$ G = OR(H, M) = 1 - (1-H)(1-M) $$\n\n4.  **Th$17$ Master Regulator Activity ($R$)**: The activity of ROR$\\gamma$t, the master transcription factor for Th$17$ cells, is a function of both STAT$3$ signaling ($S_3$) and the glycolytic state ($G$). This is first integrated with an $OR$ operation, and the result is passed through a Hill activation function to model a sharp, switch-like commitment.\n    $$ R_{\\text{base}} = OR(S_3, G) $$\n    $$ R = A(R_{\\text{base}}; K_R, n_R) $$\n    with $K_R = 0.5$ and $n_R = 2$.\n\n5.  **Treg Master Regulator Activity ($F$)**: The activity of FOXP$3$, the Treg master transcription factor, is dependent on the co-stimulation by TGF-$\\beta$ ($T$) and STAT$5$ ($S_5$), modeled with an $AND$ operation. Crucially, HIF-$1\\alpha$ ($H$) antagonizes FOXP$3$. This entire logic is captured as:\n    $$ F_{\\text{base}} = AND(T, S_5) $$\n    $$ F_{\\text{inh}} = F_{\\text{base}} \\cdot NOT(H) = F_{\\text{base}} \\cdot (1 - H) $$\n    The inhibited signal, $F_{\\text{inh}}$, then drives FOXP$3$ activity through a Hill activation:\n    $$ F = A(F_{\\text{inh}}; K_F, n_F) $$\n    with $K_F = 0.5$ and $n_F = 2$.\n\n6.  **Th$17$ Bias Score ($B$)**: The final output is a scalar score representing the bias towards the Th$17$ fate. It is the normalized activity of ROR$\\gamma$t relative to the total activity of both master regulators.\n    $$ B = \\frac{R}{R + F + \\delta} $$\n    The small regularization constant $\\delta = 10^{-9}$ is included to prevent division by zero in the trivial case where $R=0$ and $F=0$.\n\nThe computational procedure involves applying these equations in sequence for each provided $5$-tuple of inputs $(O, IL6, IL2, TGF, M)$.\n\nAs an example, let us compute the score for Case $1$: $(O, IL6, IL2, TGF, M) = (0.05, 0.8, 0.2, 0.6, 0.7)$.\n- $H = \\frac{0.3^3}{0.3^3 + 0.05^3} = \\frac{0.027}{0.027125} \\approx 0.99539$\n- $S_3 = \\frac{0.8^2}{0.5^2 + 0.8^2} = \\frac{0.64}{0.89} \\approx 0.71910$\n- $S_5 = \\frac{0.2^2}{0.5^2 + 0.2^2} = \\frac{0.04}{0.29} \\approx 0.13793$\n- $T = \\frac{0.6^2}{0.5^2 + 0.6^2} = \\frac{0.36}{0.61} \\approx 0.59016$\n- $G = 1 - (1-0.99539)(1-0.7) \\approx 0.99862$\n- $R_{\\text{base}} = 1 - (1-0.71910)(1-0.99862) \\approx 0.99961$\n- $R = \\frac{0.99961^2}{0.5^2 + 0.99961^2} \\approx \\frac{0.99922}{1.24922} \\approx 0.79988$\n- $F_{\\text{base}} = 0.59016 \\cdot 0.13793 \\approx 0.08140$\n- $F_{\\text{inh}} = 0.08140 \\cdot (1 - 0.99539) \\approx 0.000375$\n- $F = \\frac{0.000375^2}{0.5^2 + 0.000375^2} \\approx 5.625 \\times 10^{-7}$\n- $B = \\frac{0.79988}{0.79988 + 5.625 \\times 10^{-7} + 10^{-9}} \\approx 0.999999$\n\nThis procedure is repeated for all test cases. The implementation will be provided in the following section.", "answer": "```python\n# The complete and runnable Python 3 code goes here.\n# Imports must adhere to the specified execution environment.\nimport numpy as np\n\ndef solve():\n    \"\"\"\n    Implements the T cell differentiation model and computes the Th17 bias\n    score for a predefined test suite.\n    \"\"\"\n\n    # --- Model Functions ---\n\n    def hill_activation(x, k, n):\n        \"\"\"Standard Hill activation function.\"\"\"\n        # Add a small epsilon to the denominator to prevent division by zero\n        # if x and k are both zero, though inputs are in [0,1] and k in (0,1).\n        x_n = np.power(x, n)\n        k_n = np.power(k, n)\n        return x_n / (k_n + x_n)\n\n    def hill_inhibition(x, k, n):\n        \"\"\"Inhibitory Hill function for HIF-1alpha stabilization.\"\"\"\n        x_n = np.power(x, n)\n        k_n = np.power(k, n)\n        return k_n / (k_n + x_n)\n\n    def op_not(x):\n        \"\"\"Logical NOT on [0,1].\"\"\"\n        return 1.0 - x\n\n    def op_and(a, b):\n        \"\"\"Logical AND on [0,1].\"\"\"\n        return a * b\n\n    def op_or(a, b):\n        \"\"\"Logical OR on [0,1].\"\"\"\n        return 1.0 - (1.0 - a) * (1.0 - b)\n\n    # --- Model Constants ---\n    K_H = 0.3\n    n_H = 3.0\n    K_6 = 0.5\n    n_6 = 2.0\n    K_2 = 0.5\n    n_2 = 2.0\n    K_T = 0.5\n    n_T = 2.0\n    K_R = 0.5\n    n_R = 2.0\n    K_F = 0.5\n    n_F = 2.0\n    DELTA = 1e-9\n\n    # --- Test Suite ---\n    test_cases = [\n        (0.05, 0.8, 0.2, 0.6, 0.7),  # Case 1\n        (0.9, 0.8, 0.2, 0.6, 0.7),   # Case 2\n        (0.9, 0.1, 0.9, 0.6, 0.3),   # Case 3\n        (0.1, 0.0, 0.0, 0.0, 0.0),   # Case 4\n        (0.01, 0.2, 1.0, 0.8, 0.5),  # Case 5\n        (0.2, 0.5, 0.4, 0.7, 0.9),   # Case 6\n    ]\n\n    results = []\n    for case in test_cases:\n        O, IL6, IL2, TGF, M = case\n\n        # 1. HIF stabilization\n        H = hill_inhibition(O, K_H, n_H)\n\n        # 2. Cytokine transducers\n        S3 = hill_activation(IL6, K_6, n_6)\n        S5 = hill_activation(IL2, K_2, n_2)\n        T = hill_activation(TGF, K_T, n_T)\n\n        # 3. Glycolysis proxy\n        G = op_or(H, M)\n\n        # 4. Th17 master regulator (RORgt)\n        R_base = op_or(S3, G)\n        R = hill_activation(R_base, K_R, n_R)\n\n        # 5. Treg master regulator (FOXP3)\n        F_base = op_and(T, S5)\n        F_inh = F_base * op_not(H)\n        F = hill_activation(F_inh, K_F, n_F)\n\n        # 6. Th17 bias score\n        B = R / (R + F + DELTA)\n        \n        # Format result to 6 decimal places\n        results.append(f\"{B:.6f}\")\n\n    # Final print statement in the exact required format.\n    print(f\"[{','.join(results)}]\")\n\nsolve()\n```", "id": "2868713"}]}